PVLA
Palvella Therapeutics, Inc
138.80$
+5.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.49 | 3.42 | 7.08 | 32.26 | 6.64 | 17.33 | 12.34 | 7.26 | 13.44 | 8.67 | 24.53 | 25.02 | 19.21 | 17.18 | 4.33 | 2.68 | 22.22 | 4.25 | 4.79 | 9.35 | 11.93 | 3.99 | 5.77 | 6.28 | 1.91 | 18.27 | 15.79 | 1.05 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.19 | 0.21 | 0.10 | – | 0.21 | 0.21 | 0.19 | – | – | – | – | – | – | – | – | – | – | – | – | 0.65 | 0.91 | 0.62 | 0.83 | 0.63 | 0.56 | 0.66 | 0.60 | – | -0.02 | – | – | – | – | – | – | – | – | – | – | |
| 2.31 | 3.21 | 6.98 | – | 6.42 | 17.12 | 12.15 | – | – | – | – | – | – | – | – | – | – | – | – | 8.70 | 11.01 | 3.37 | 4.94 | 5.65 | 1.35 | 17.60 | 15.19 | 1.05 | – | – | – | – | – | – | – | – | – | – | – | |
| 9.77 | 9.74 | 11.18 | 9.19 | 12.47 | 13.36 | 16.67 | 18.96 | 22.48 | 21.74 | 21.41 | 20.07 | 17.99 | 16.50 | 16.29 | 14.19 | 22.65 | 19.62 | 21.65 | 16.34 | 14.35 | 12.26 | 13.79 | 13.76 | 12.64 | 12.36 | 7.76 | 3.60 | 0.78 | 1.11 | 2.42 | 1.14 | 1.83 | 0.46 | 0.59 | 0.63 | 0.71 | 0.87 | 2.47 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.91 | – | – | – | 0.61 | 1.13 | 1.42 | 0.82 | 1.71 | 0.37 | 0.33 | 0.37 | 0.42 | 0.62 | 1.55 | |
| 17.18 | 17.75 | 16.32 | 20.55 | 19.43 | 20.44 | 23.69 | 25.70 | 29.98 | 28.49 | 28.99 | 25.98 | 24.02 | 23.48 | 22.74 | 19.54 | 28.55 | 25.14 | 26.56 | 20.88 | 19.11 | 16.68 | 18.03 | 18.03 | 16.64 | 15.73 | 12.70 | 5.48 | 1.39 | 2.25 | 3.83 | 1.96 | 3.54 | 0.84 | 0.92 | 1.00 | 1.14 | 1.49 | 4.02 | |
| -14.87 | -14.54 | -9.34 | 11.53 | -13.01 | -3.32 | -11.54 | -18.69 | -16.80 | -19.88 | -4.72 | -1.93 | -5.59 | -7.11 | -19.14 | -17.73 | -7.19 | -21.66 | -22.46 | -12.18 | -8.09 | -13.31 | -13.08 | -12.38 | -15.29 | 1.88 | 2.50 | -4.43 | -1.39 | -2.25 | -3.83 | -1.96 | -3.54 | -0.84 | -0.92 | -1.00 | -1.14 | -1.49 | -4.02 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.01 | 0.00 | – | – | – | 2.54 | – | – | – | 0.63 | 0.82 | 0.94 | 0.59 | 0.55 | 0.12 | 0.14 | 0.15 | 0.16 | 0.16 | 0.53 | |
| -14.85 | -17.09 | -12.46 | 13.57 | -13.93 | -0.52 | -9.10 | -17.50 | -16.27 | -19.12 | -4.20 | -1.12 | -5.21 | -7.56 | -21.03 | -20.34 | -5.93 | -20.03 | -19.53 | -10.56 | -5.54 | -11.16 | -10.47 | -8.70 | -13.00 | 3.62 | -8.70 | -3.71 | -2.00 | -3.22 | -5.13 | -1.77 | -3.68 | -0.86 | -1.03 | -1.13 | -1.20 | -1.52 | -4.30 | |
| – | 1.50 | 0.26 | 0.26 | – | -0.22 | – | -0.24 | – | – | – | – | – | – | – | 0.23 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -14.85 | -18.59 | -12.72 | 13.31 | -13.93 | -0.30 | -9.10 | -17.26 | -16.27 | -19.12 | -4.20 | -1.12 | -5.21 | -7.56 | -21.03 | -20.57 | -5.93 | -20.03 | -19.53 | -10.56 | -5.54 | -11.16 | -10.47 | -8.70 | -13.00 | 3.62 | -8.70 | -3.71 | -2.00 | -3.22 | -5.13 | -1.77 | -3.68 | -0.86 | -1.03 | -1.13 | -1.20 | -1.52 | -4.30 | |
| -14.66 | -16.88 | -12.36 | 13.75 | -13.72 | -0.31 | -8.91 | -17.26 | -16.01 | -19.05 | -3.94 | -0.14 | -4.43 | -6.75 | -20.30 | -19.47 | -5.08 | -19.26 | -18.84 | -9.90 | -4.62 | -10.54 | -9.64 | -8.08 | -12.44 | 4.28 | -8.10 | -3.71 | -1.37 | -2.41 | -1.30 | -1.19 | -3.13 | -0.73 | 0.03 | -0.98 | -1.36 | -1.50 | -3.48 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.